W. Stevens

发表

Implementation and Operational Research: Implementation of Multiple Point-of-Care Testing in 2 HIV Antiretroviral Treatment Clinics in South Africa

N. Gous, L. Scott, J. Potgieter, 2016, Journal of acquired immune deficiency syndromes.

Dried Culture Spots for Xpert MTB/RIF External Quality Assessment: Results of a Phase 1 Pilot Study in South Africa

B. Kana, N. Gous, L. Scott, 2011, Journal of Clinical Microbiology.

Antiretroviral prophylaxis for HIV prevention in heterosexual men and women.

James D. Campbell, J. Baeten, J. Tappero, 2012, The New England journal of medicine.

Evaluation of an oligonucleotide ligation assay for detection of mutations in HIV-1 subtype C individuals who have high level resistance to nucleoside reverse transcriptase inhibitors and non-nucleoside reverse transcriptase inhibitors.

L. Morris, W. Stevens, C. Wallis, 2005, Journal of virological methods.

Early ART Results in Greater Immune Reconstitution Benefits in HIV-Infected Infants: Working with Data Missingness in a Longitudinal Dataset

L. Montaner, E. Papasavvas, L. Azzoni, 2015, PloS one.

Imputing HIV treatment start dates from routine laboratory data in South Africa: a validation study

T. Bärnighausen, D. Pillay, W. MacLeod, 2017, BMC Health Services Research.

Emergence of X4 usage among HIV-1 subtype C: evidence for an evolving epidemic in South Africa

A. Capovilla, W. Stevens, M. Papathanasopoulos, 2008, AIDS.

Suboptimal immune recovery during antiretroviral therapy with sustained HIV suppression in sub-Saharan Africa

T. F. Rinke de Wit, P. Reiss, F. Wit, 2018, AIDS.

HIV-1 Phenotypic Reverse Transcriptase Inhibitor Drug Resistance Test Interpretation Is Not Dependent on the Subtype of the Virus Backbone

L. Stuyver, W. Stevens, H. de Wolf, 2012, PloS one.

Will etravirine work in patients failing nonnucleoside reverse transcriptase inhibitor-based treatment in southern Africa?

I. Sanne, W. Stevens, C. Wallis, 2009, Journal of acquired immune deficiency syndromes.

The Impact and Cost of Scaling up GeneXpert MTB/RIF in South Africa

W. MacLeod, I. Sanne, W. Stevens, 2012, PloS one.

Affordable in-house antiretroviral drug resistance assay with good performance in non-subtype B HIV-1.

A. Kamali, P. Kaleebu, E. Karita, 2010, Journal of virological methods.

African regional external quality assessment for CD4 T‐cell enumeration: Development, outcomes, and performance of laboratories

W. Stevens, F. Mandy, D. Glencross, 2008, Cytometry. Part B, Clinical cytometry.

Impact and costs of algorithms for the diagnosis of adults with pulmonary tuberculosis in South Africa.

I. Sanne, W. Stevens, L. Long, 2013, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

Time to Treatment and Patient Outcomes among TB Suspects Screened by a Single Point-of-Care Xpert MTB/RIF at a Primary Care Clinic in Johannesburg, South Africa

L. Scott, I. Sanne, W. Stevens, 2013, PloS one.

Scaling up Xpert MTB/RIF technology: the costs of laboratory- vs. clinic-based roll-out in South Africa

W. MacLeod, I. Sanne, W. Stevens, 2012, Tropical medicine & international health : TM & IH.

Cost and Impact of Dried Blood Spot Versus Plasma Separation Card for Scale-up of Viral Load Testing in Resource-limited Settings

C. Gill, B. Nichols, L. Scott, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Implications of Failure to Routinely Diagnose Resistance to Second-Line Drugs in Patients With Rifampicin-Resistant Tuberculosis on Xpert MTB/RIF: A Multisite Observational Study

P. V. van Helden, R. Warren, L. Scott, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Cost-effectiveness of adoption strategies for point of care HIV viral load monitoring in South Africa

P. Drain, N. Garrett, J. Dorward, 2020, EClinicalMedicine.

Monitoring viral load for the last mile: what will it cost?

L. Berrie, D. Chimhamhiwa, B. Nichols, 2019, Journal of the International AIDS Society.

Impact of a borderless sample transport network for scaling up viral load monitoring: results of a geospatial optimization model for Zambia

L. Berrie, D. Chimhamhiwa, B. Nichols, 2018, Journal of the International AIDS Society.

The net cost of incorporating resistance testing into HIV/AIDS treatment in South Africa: a Markov model with primary data

S. Rosen, M. Fox, I. Sanne, 2011, Journal of the International AIDS Society.

The role of serological testing in the SARS-CoV-2 outbreak.

H. Rees, W. Preiser, L. Scott, 2020, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

Monitored Implementation of COVID-19 Rapid Antigen Screening at Taxi Ranks in Johannesburg, South Africa

Sanjida Karim, L. Scott, W. Stevens, 2022, Diagnostics.

Xpert® MTB/RIF for point-of-care diagnosis of TB in high-HIV burden, resource-limited countries: hype or hope?

L. Scott, I. Sanne, W. Stevens, 2010, Expert review of molecular diagnostics.

belens, F; Stevens, W; Nicol, M (2017) Delays and loss to follow-up before treatment of drug-resistant tuberculosis following implemen- tation of Xpert MTB/RIF in South Africa: A retrospective cohort

F. Cobelens, M. Nicol, A. Grant, 2018 .

Performance of Xpert® MTB/RIF among tuberculosis outpatients in Lilongwe, Malawi

I. Hoffman, N. Rosenberg, L. Scott, 2017, African journal of laboratory medicine.

Delays and loss to follow-up before treatment of drug-resistant tuberculosis following implementation of Xpert MTB/RIF in South Africa: A retrospective cohort study

F. Cobelens, M. Nicol, A. Grant, 2017, PLoS medicine.

The impact of Xpert(®) MTB/RIF in sparsely populated rural settings.

I. Sanne, W. Stevens, A. Van Rie, 2015, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Diagnosing Xpert MTB/RIF negative TB: impact and cost of alternative algorithms for South Africa.

I. Sanne, W. Stevens, L. Long, 2013, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

Point-of-care Xpert® MTB/RIF for smear-negative tuberculosis suspects at a primary care clinic in South Africa.

L. Scott, I. Sanne, W. Stevens, 2013, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Diminished Human Immunodeficiency Virus Type 1 DNA Yield from Dried Blood Spots after Storage in a Humid Incubator at 37°C Compared to −20°C

Ingrid A. Beck, G. Aldrovandi, J. Fitzgibbon, 2008, Journal of Clinical Microbiology.

High-Level Cross-Resistance to Didanosine Observed in South African Children Failing an Abacavir- or Stavudine-Based 1st-Line Regimen

W. Stevens, M. Papathanasopoulos, K. Steegen, 2014, PloS one.

Characterization of Lymphomas in a High Prevalence HIV Setting

W. Stevens, T. Wiggill, S. Carmona, 2010, Journal of acquired immune deficiency syndromes.

Genotypic characterization and comparison of full-length envelope glycoproteins from South African HIV type 1 subtype C primary isolates that utilize CCR5 and/or CXCR4.

A. Capovilla, W. Stevens, M. Papathanasopoulos, 2008, AIDS research and human retroviruses.

DIAGNOSIS OF HUMAN IMMUNODEFICIENCY VIRUS INFECTION IN PERINATALLY EXPOSED ORPHANED INFANTS IN A RESOURCE-POOR SETTING

W. Stevens, G. Stevens, G. Sherman, 2000, The Pediatric infectious disease journal.

The Performance of the Abbott Real Time MTB RIF/INH Compared to the MTBDRplus V2 for the Identification of MDR-TB Among Isolates

L. Scott, W. Stevens, P. D. da Silva, 2020, Infection and drug resistance.

Molecular characterisation of rifampicin-resistant Mycobacterium tuberculosis strains from Malawi

I. Hoffman, N. Rosenberg, L. Scott, 2017, African journal of laboratory medicine.

Performance of the Roche LightCycler Real-Time PCR Assay for Diagnosing Extrapulmonary Tuberculosis

W. Venter, N. Gous, L. Scott, 2012, Journal of Clinical Microbiology.

Development and Evaluation of an Affordable Real-Time Qualitative Assay for Determining HIV-1 Virological Failure in Plasma and Dried Blood Spots

T. F. Rinke de Wit, T. de Oliveira, C. Kityo, 2013, Journal of Clinical Microbiology.

Development and evaluation of an assay for HIV-1 protease and reverse transcriptase drug resistance genotyping of all major group-M subtypes.

T. F. Rinke de Wit, R. Barth, W. Stevens, 2012, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Transmitted HIV type 1 drug resistance among individuals with recent HIV infection in East and Southern Africa.

A. Kamali, P. Kaleebu, E. Karita, 2011, AIDS research and human retroviruses.

What causes symptoms suggestive of tuberculosis in HIV-positive people with negative initial investigations?

M. Nicol, S. Charalambous, A. Grant, 2019, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

High incidence of latent tuberculous infection among South African health workers: an urgent call for action.

W. Venter, N. Gous, L. Scott, 2015, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Frequent emergence of N348I in HIV-1 subtype C reverse transcriptase with failure of initial therapy reduces susceptibility to reverse-transcriptase inhibitors.

J. Mellors, K. Shutt, R. Wood, 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Extension of a cold-labelled oligoprobe for the analysis of PCR products

W. Stevens, B. Mendelow, R. D. Lastrucci, 1998 .

Comparative Analytical Evaluation of Four Centralized Platforms for the Detection of Mycobacterium tuberculosis Complex and Resistance to Rifampicin and Isoniazid

C. Denkinger, L. Scott, W. Stevens, 2020, Journal of Clinical Microbiology.

Performance of Xpert MTB/RIF, Xpert Ultra, and Abbott RealTime MTB for Diagnosis of Pulmonary Tuberculosis in a High-HIV-Burden Setting

L. Scott, I. Sanne, W. Stevens, 2018, Journal of Clinical Microbiology.

Performance of the Abbott RealTime MTB and MTB RIF/INH Assays in a Setting of High Tuberculosis and HIV Coinfection in South Africa

L. Scott, W. Stevens, P. D. da Silva, 2017, Journal of Clinical Microbiology.

Long-term HIV treatment outcomes and associated factors in sub-Saharan Africa: multicountry longitudinal cohort analysis

K. Mandaliya, T. S. Boender, C. Kityo, 2022, AIDS.

Diagnosis of opportunistic infections: HIV co-infections – tuberculosis

C. Boehme, L. Scott, W. Stevens, 2017, Current opinion in HIV and AIDS.

Multicenter Feasibility Study To Assess External Quality Assessment Panels for Xpert MTB/RIF Assay in South Africa

L. Scott, W. Stevens, C. Gilpin, 2014, Journal of Clinical Microbiology.

Performance Monitoring of Mycobacterium tuberculosis Dried Culture Spots for Use with the GeneXpert System within a National Program in South Africa

B. Kana, N. Gous, L. Scott, 2013, Journal of Clinical Microbiology.

Perspectives on introduction and implementation of new point-of-care diagnostic tests.

M. Schito, G. Domingo, W. Stevens, 2012, The Journal of infectious diseases.

A Pilot Evaluation of External Quality Assessment of GenoType MTBDRplus Versions 1 and 2 Using Dried Culture Spot Material

N. Gous, L. Scott, W. Stevens, 2015, Journal of Clinical Microbiology.

Diagnosing childhood pulmonary tuberculosis using a single sputum specimen on Xpert MTB/RIF at point of care.

N. Gous, L. Scott, W. Stevens, 2015, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

The patient impact of point-of-care vs. laboratory placement of Xpert(®) MTB/RIF.

L. Scott, I. Sanne, W. Stevens, 2015, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Increased Microbial Translocation in ≤180 Days Old Perinatally Human Immunodeficiency Virus-positive Infants as Compared With Human Immunodeficiency Virus-exposed Uninfected Infants of Similar Age

L. Montaner, E. Papasavvas, M. Pistilli, 2011, The Pediatric infectious disease journal.

Ultrasensitive Human Immunodeficiency Virus Type 1 p24 Antigen Assay Modified for Use on Dried Whole-Blood Spots as a Reliable, Affordable Test for Infant Diagnosis

W. Stevens, A. Coovadia, G. Sherman, 2006, Clinical and Vaccine Immunology.

FOXP3 Expression Is Upregulated in CD4+T Cells in Progressive HIV-1 Infection and Is a Marker of Disease Severity

C. Gray, W. Stevens, M. Suchard, 2010, PloS one.

Discordances between molecular assays for rifampicin resistance in Mycobacterium tuberculosis: frequency, mechanisms and clinical impact.

T. Heupink, R. Warren, L. Scott, 2020, The Journal of antimicrobial chemotherapy.

Early assessment of the clinical severity of the SARS-CoV-2 Omicron variant in South Africa

J. Bhiman, C. Scheepers, R. Parboosing, 2021, medRxiv.

Antiretroviral therapy interruptions result in loss of protective humoral immunity to neoantigens in HIV-infected individuals

L. Montaner, R. Gross, Z. Xiang, 2012, AIDS.

Evaluation of the Performance of the Automated NucliSENS easyMAG and EasyQ Systems versus the Roche AmpliPrep-AMPLICOR Combination for High-Throughput Monitoring of Human Immunodeficiency Virus Load

L. Scott, W. Stevens, P. Horsfield, 2007, Journal of Clinical Microbiology.

Increased Platelet and Microparticle Activation in HIV Infection: Upregulation of P-Selectin and Tissue Factor Expression

M. Lederman, A. Schmaier, S. Sieg, 2012, Journal of acquired immune deficiency syndromes.

Comparisons of Human Immunodeficiency Virus Type 1 Envelope Variants in Blood and Genital Fluids near the Time of Male-to-Female Transmission

J. Mullins, H. Rees, A. Wald, 2019, Journal of Virology.

Progress with Scale-Up of HIV Viral Load Monitoring - Seven Sub-Saharan African Countries, January 2015-June 2016.

M. Mwasekaga, J. Nkengasong, W. MacLeod, 2016, MMWR. Morbidity and mortality weekly report.

Oral abstracts of the 21st International AIDS Conference 18–22 July 2016, Durban, South Africa

Michael I. Jordan, Donald A. Jackson, J. G. Ndirangu, 2016, Journal of the International AIDS Society.

Impact of aciclovir on genital and plasma HIV-1 RNA in HSV-2/HIV-1 co-infected women: a randomized placebo-controlled trial in South Africa

H. Rees, T. Clayton, A. Capovilla, 2009, AIDS.

Nurse management is not inferior to doctor management of antiretroviral patients: The CIPRA South Africa randomised trial

R. Wood, C. Orrell, M. Dehlinger, 2011 .

The cobas® 6800/8800 System: a new era of automation in molecular diagnostics

L. Katz, W. Stevens, O. Liesenfeld, 2017, Expert review of molecular diagnostics.

HIV and Sexual Behaviour Among Young South Africans: A national survey of 15-24 year olds

S. Kegeles, S. Shiboski, N. Padian, 2004 .

Polychromatic immunophenotypic characterization of T cell profiles among HIV-infected patients experiencing immune reconstitution inflammatory syndrome (IRIS)

C. Feldman, W. Stevens, K. Weinhold, 2009, AIDS research and therapy.

Estimating retention in HIV care accounting for patient transfers: A national laboratory cohort study in South Africa

W. MacLeod, M. Fox, W. Stevens, 2018, PLoS medicine.

Operational characteristics of 30 lateral flow immunoassays used to identify COVID-19 immune response

L. Scott, W. Stevens, E. Mayne, 2021, Journal of Immunological Methods.

The performance of using dried blood spot specimens for HIV-1 viral load testing: A systematic review and meta-analysis

Marta R Prescott, D. Boeras, T. Peter, 2022, PLoS medicine.

HIV-1 Drug Resistance Mutations Are Present in Six Percent of Persons Initiating Antiretroviral Therapy in Lusaka, Zambia

T. F. Rinke de Wit, A. Wensing, W. Stevens, 2010, Journal of acquired immune deficiency syndromes.

Comparison of three nasopharyngeal swab types and the impact of physiochemical properties for optimal SARS-CoV-2 detection

L. Scott, W. Stevens, L. Noble, 2020, medRxiv.

Identifying acute HIV infection--a major new public health challenge.

H. Rees, W. Stevens, Mandy F. Myers, 2004, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

Frequent Emergence of N 348 I in HIV-1 Subtype C Reverse Transcriptase with Failure of Initial Therapy Reduces Susceptibility to Reverse-Transcriptase Inhibitors

J. Mellors, K. Shutt, R. Wood, 2012 .

Diagnosis and monitoring of HIV programmes to support treatment initiation and follow up and improve programme quality

N. Ford, W. Venter, W. Stevens, 2017, Current opinion in HIV and AIDS.

Viral tropism and antiretroviral drug resistance in HIV-1 subtype C-infected patients failing highly active antiretroviral therapy in Johannesburg, South Africa.

W. Stevens, M. Papathanasopoulos, K. Steegen, 2014, AIDS research and human retroviruses.

Evaluation of the NucliSens EasyQ assay in HIV-1-infected individuals in South Africa.

L. Scott, W. Stevens, T. Wiggill, 2005, Journal of virological methods.

Laboratory expansion to large-scale international HIV preventive vaccine trials

C. Gray, M. de Souza, W. Stevens, 2007, Current opinion in HIV and AIDS.

Development and evaluation of an affordable real-time qualitative assay for deter-1 mining HIV-1 virological failure in plasma and dried blood spots 2 3

C. Kityo, W. Stevens, C. Wallis, 2013 .

Reply to 'Quantification of HIV-1 RNA on Dried Blood Spots' AIDS 24:475-6.

J. Crump, J. Bartlett, S. Lofgren, 2010, AIDS.

SARS-CoV-2 antigens expressed in plants detect antibody responses in 1 COVID-19 patients 2

L. Scott, I. Sanne, W. Stevens, 2020 .

Emergence of SARS-CoV-2 Omicron lineages BA.4 and BA.5 in South Africa

O. Pybus, A. Rambaut, C. Althaus, 2022, Nature Medicine.

Tuberculosis in children dying with HIV-related lung disease: clinical-pathological correlations.

W. Stevens, G. Stevens, W. Rennert, 2002, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Affordable diagnosis of human immunodeficiency virus infection in infants by p24 antigen detection

W. Stevens, G. Stevens, G. Sherman, 2004, The Pediatric infectious disease journal.

Fluorogenic LUX primer for quantitation of HIV-1 by real-time RT-PCR

L. Scott, W. Stevens, G. Stevens, 2006, Molecular biotechnology.

Use of a Prequalification Panel for Rapid Scale-Up of High-Throughput HIV Viral Load Testing

Melanie Mackay, N. Gous, W. Stevens, 2012, Journal of Clinical Microbiology.

Title: The performance of the new Roche COBAS Ampliprep/ COBAS TaqMan HIV-1

L. Scott, W. Stevens, S. Carmona, 2009 .

Assay Human Immunodeficiency Virus Type 1 AmpliPrep-Cobas TaqMan Version 2 . 0 Performance of the New Roche Cobas

L. Scott, W. Stevens, S. Carmona, 2009 .

Performance of a Novel Human Immunodeficiency Virus (HIV) Type 1 Total Nucleic Acid-Based Real-Time PCR Assay Using Whole Blood and Dried Blood Spots for Diagnosis of HIV in Infants

W. Stevens, L. Erasmus, M. Moloi, 2008, Journal of Clinical Microbiology.

mining HIV-1 virological failure in plasma and dried blood spots

C. Kityo, W. Stevens, C. Wallis, 2013 .

Comparison of Cervicovaginal Lavage, Cervicovaginal Lavage Enriched With Cervical Swab, and Vaginal Tampon for the Detection of HIV-1 RNA and HSV-2 DNA in Genital Secretions

T. Clayton, A. Capovilla, L. Bélec, 2008, Journal of acquired immune deficiency syndromes.

South Africa’s experience with provision of quality HIV diagnostic services

L. Berrie, N. Gous, W. Stevens, 2016, African journal of laboratory medicine.

Evaluation of a dried blood spot HIV-1 RNA program for early infant diagnosis and viral load monitoring at rural and remote healthcare facilities

J. Crump, J. Bartlett, S. Lofgren, 2009, AIDS.

HIV–HBV Coinfection in Southern Africa and the Effect of Lamivudine- Versus Tenofovir-Containing cART on HBV Outcomes

T. F. Rinke de Wit, W. Stevens, R. Hamers, 2013, Journal of acquired immune deficiency syndromes.

Improved Sensitivity of a Dual-Target HIV-1 Qualitative Test for Plasma and Dried Blood Spots

W. Stevens, C. Seguin-Devaux, S. Carmona, 2016, Journal of Clinical Microbiology.

Bone marrow morphology in human immunodeficiency virus‐infected South Africans with and without tuberculosis

W. Stevens, A. Karstaedt, L. Pantanowitz, 2001, British journal of haematology.

Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis

Connie Celum, Wendy Stevens, Deborah Donnell, 2010, The Lancet.

Validation of Roche immunoassay for severe acute respiratory coronavirus 2 in South Africa

L. Scott, I. Sanne, W. Stevens, 2021, Southern African Journal of Infectious Diseases.

Performance of the EUROIMMUN Anti-SARS-CoV-2 ELISA Assay for detection of IgA and IgG antibodies in South Africa

J. Blackburn, L. Scott, I. Sanne, 2021, PloS one.

SARS-CoV-2 Antigens Expressed in Plants Detect Antibody Responses in COVID-19 Patients

J. Blackburn, L. Scott, I. Sanne, 2020, Frontiers in Plant Science.

Stabilization of HIV-1 gp120-CD4 Receptor Complex through Targeted Interchain Disulfide Exchange*

Wendy Stevens, A. Capovilla, W. Stevens, 2010, The Journal of Biological Chemistry.

Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2.

J. Mullins, J. Baeten, S. Kapiga, 2010, The New England journal of medicine.

HIV/AIDS prevalence testing--merits, methodology and outcomes of a survey conducted at a large mining organisation in South Africa.

L. Scott, W. Stevens, G. Napier, 2006, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

Comparison of Xpert MTB/RIF with Other Nucleic Acid Technologies for Diagnosing Pulmonary Tuberculosis in a High HIV Prevalence Setting: A Prospective Study

W. Venter, N. Gous, L. Scott, 2011, PLoS medicine.

The future role of CD4 cell count for monitoring antiretroviral therapy.

N. Ford, P. Phanuphak, A. Calmy, 2015, The Lancet. Infectious diseases.

Affordable HIV drug-resistance testing for monitoring of antiretroviral therapy in sub-Saharan Africa.

T. Peter, W. Stevens, R. Hamers, 2016, The Lancet. Infectious diseases.

A clinical scoring system to prioritise investigation for tuberculosis among adults attending HIV clinics in South Africa

A. Vassall, M. Nicol, S. Charalambous, 2017, PloS one.

Natural polymorphisms of integrase among HIV type 1-infected South African patients.

W. Stevens, C. Wallis, M. Papathanasopoulos, 2010, AIDS research and human retroviruses.

Chapter 2 The 2008 status of HIV-1 resistance to antiretroviral drugs in sub-Saharan Africa

T. R. D. Wit, W. Stevens, R. Hamers, 2013 .

The Status of HIV-1 Resistance to Antiretroviral Drugs in Sub-Saharan Africa

T. F. Rinke de Wit, W. Stevens, R. Hamers, 2008, Antiviral therapy.

The Status of HIV-1 Resistance to Antiretroviral drugs in Sub-Saharan Africa

T. F. Rinke de Wit, W. Stevens, R. Hamers, 2008, Antiviral Therapy.

Can oral fluid testing be used to replace blood-based HIV rapid testing to improve access to diagnosis in South Africa?

L. Scott, W. Stevens, U. Jentsch, 2009, Journal of acquired immune deficiency syndromes.

Low Prevalence of Liver Disease but Regional Differences in HBV Treatment Characteristics Mark HIV/HBV Co-Infection in a South African HIV Clinical Trial

R. Wood, C. Orrell, W. MacLeod, 2013, PloS one.

Laboratory Evaluation of the Liat HIV Quant (IQuum) Whole-Blood and Plasma HIV-1 Viral Load Assays for Point-of-Care Testing in South Africa

N. Gous, L. Scott, W. Stevens, 2015, Journal of Clinical Microbiology.

Evaluation of Dried Whole Blood Spots Obtained by Heel or Finger Stick as an Alternative to Venous Blood for Diagnosis of Human Immunodeficiency Virus Type 1 Infection in Vertically Exposed Infants in the Routine Diagnostic Laboratory

Wendy S. Stevens, W. Stevens, A. Coovadia, 2006, Clinical and Vaccine Immunology.

Dried Blood Spots Improve Access to HIV Diagnosis and Care for Infants in Low-Resource Settings

Wendy S Stevens, Stephanie A. Jones, W. Stevens, 2005, Journal of acquired immune deficiency syndromes.

Sustainable HIV treatment in Africa through viral-load-informed differentiated care

Jeffrey W. Eaton, Rosanna Peeling, Zachary Katz, 2015, Nature.

Performance of the PointCare NOW System for CD4 Counting in HIV Patients Based on Five Independent Evaluations

T. Peter, I. Jani, L. Scott, 2012, PloS one.

Evaluating new CD4 enumeration technologies for resource-constrained countries

R. Gelman, L. Scott, W. Stevens, 2008, Nature Reviews Microbiology.

Large‐scale affordable Panleucogated CD4+ testing with proactive internal and external quality assessment: In support of the South African national comprehensive care, treatment and management programme for HIV and AIDS

G. Janossy, I. Sanne, W. Stevens, 2008, Cytometry. Part B, Clinical cytometry.

HIV-1 drug resistance in antiretroviral-naive individuals in sub-Saharan Africa after rollout of antiretroviral therapy: a multicentre observational study.

Kishor Mandaliya, Wendy S Stevens, Raph L Hamers, 2011, The Lancet. Infectious diseases.

High Prevalence of the K65R Mutation in HIV-1 Subtype C Infected Patients Failing Tenofovir-Based First-Line Regimens in South Africa

W. Stevens, M. Papathanasopoulos, K. Steegen, 2015, PloS one.

A randomized trial of two postexposure prophylaxis regimens to reduce mother-to-child HIV-1 transmission in infants of untreated mothers

G. Gray, J. McIntyre, W. Stevens, 2005, AIDS.

CLSI-Derived Hematology and Biochemistry Reference Intervals for Healthy Adults in Eastern and Southern Africa

A. Kamali, P. Kaleebu, E. Karita, 2009, PloS one.

Kaposi Sarcoma-Associated Herpesvirus/Human Herpesvirus 8 and Multiple Myeloma in South Africa

J. Mahlangu, W. Stevens, W. Stevens, 2001, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

Early antiretroviral therapy initiation: access and equity of viral load testing for HIV treatment monitoring.

N. Ford, D. Boeras, T. Peter, 2017, The Lancet. Infectious diseases.

Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa

M. Kraemer, O. Pybus, L. du Plessis, 2021, Nature.

Xpert MTB/RIF versus sputum microscopy as the initial diagnostic test for tuberculosis: a cluster-randomised trial embedded in South African roll-out of Xpert MTB/RIF.

Christopher Dye, Edina Sinanovic, Anna Vassall, 2015, The Lancet. Global health.

Increased tissue factor expression on circulating monocytes in chronic HIV infection: relationship to in vivo coagulation and immune activation.

M. Lederman, D. Douek, J. Brenchley, 2010, Blood.

Automated sequence analysis and editing software for HIV drug resistance testing.

T. F. Rinke de Wit, Gennady Denisov, D. Struck, 2012, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Baseline Morbidity in 2,990 Adult African Volunteers Recruited to Characterize Laboratory Reference Intervals for Future HIV Vaccine Clinical Trials

A. Kamali, P. Kaleebu, E. Karita, 2008, PloS one.

Quantifying HIV for monitoring antiretroviral therapy in resource-poor settings.

Lesley E Scott, Wendy S Stevens, L. Scott, 2010, The Journal of infectious diseases.

Clinical performance of an in-house real-time RT-PCR assay using a fluorogenic LUX primer for quantitation of human immunodeficiency virus type-1 (HIV-1).

R. Wood, J. McIntyre, W. Stevens, 2007, Journal of virological methods.

Evaluation of Two Commercially Available, Inexpensive Alternative Assays Used for Assessing Viral Load in a Cohort of Human Immunodeficiency Virus Type 1 Subtype C-Infected Patients from South Africa

L. Scott, W. Stevens, R. Gonin, 2005, Journal of Clinical Microbiology.

Acyclovir Prophylaxis Reduces the Incidence of Herpes Zoster Among HIV-Infected Individuals: Results of a Randomized Clinical Trial.

J. Baeten, S. Delany-Moretlwe, S. Kapiga, 2016, The Journal of infectious diseases.

Xpert MTB/RIF Ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy study

S. Dorman, D. Alland, S. Chakravorty, 2018, The Lancet. Infectious diseases.

Studies of a prophylactic HIV-1 vaccine candidate based on modified vaccinia virus Ankara (MVA) with and without DNA priming: effects of dosage and route on safety and immunogenicity.

G. Pantaleo, A. McMichael, W. Jaoko, 2007, Vaccine.

Viral Genetic Determinants of Non Progressive Hiv-1 Subtype C Infection in Antiretroviral Drug Naïve Children Publications Conference Proceedings Viral Genetic Determinants of Nonprogressive Hiv-1 Subtype C Infection in Antiretroviral Drug

W. Stevens, M. Papathanasopoulos, C. Tiemessen, 2022 .

Effect of pretreatment HIV-1 drug resistance on immunological, virological, and drug-resistance outcomes of first-line antiretroviral treatment in sub-Saharan Africa: a multicentre cohort study.

F. Wit, K. Mandaliya, C. Kityo, 2012, The Lancet. Infectious diseases.

Eff ect of pretreatment HIV-1 drug resistance on immunological , virological , and drug-resistance outcomes of fi rst-line antiretroviral treatment in sub-Saharan Africa : a multicentre cohort study

K. Mandaliya, C. Kityo, W. Stevens, 2011 .

Options to Expand HIV Viral Load Testing in South Africa: Evaluation of the GeneXpert® HIV-1 Viral Load Assay

Leigh Berrie, Lesley Scott, Wendy Stevens, 2016, PloS one.

Dried Fluid Spots for HIV Type-1 Viral Load and Resistance Genotyping: A Systematic Review

T. F. Rinke de Wit, W. Stevens, R. Hamers, 2009, Antiviral therapy.

CD8/CD38 activation yields important clinical information of effective antiretroviral therapy: Findings from the first year of the CIPRA‐SA cohort

G. Janossy, I. Sanne, W. Stevens, 2008, Cytometry. Part B, Clinical cytometry.

Challenges in implementing HIV load testing in South Africa.

Wendy S Stevens, W. Stevens, Theresa M Marshall, 2010, The Journal of infectious diseases.

Stability of HIV-1 Nucleic Acids in Dried Blood Spot Samples for HIV-1 Drug Resistance Genotyping

W. Stevens, C. Wallis, R. Schuurman, 2015, PloS one.

Nurse versus doctor management of HIV-infected patients receiving antiretroviral therapy (CIPRA-SA): a randomised non-inferiority trial

R. Wood, C. Orrell, M. Dehlinger, 2010, The Lancet.

Role of the Laboratory in Ensuring Global Access to ARV Treatment for HIV-Infected Children: Consensus Statement on the Performance of Laboratory Assays for Early Infant Diagnosis

J. Nkengasong, W. Stevens, T. Finkbeiner, 2008, The open AIDS journal.

Revised guidelines for diagnosis of perinatal HIV-1 infection in South Africa

W. Stevens, G. Sherman, L. Webber, 2006 .

Patterns of HIV-1 drug resistance after first-line antiretroviral therapy (ART) failure in 6 sub-Saharan African countries: implications for second-line ART strategies.

T. F. Rinke de Wit, A. Wensing, K. Mandaliya, 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

HIV-1 antiretroviral drug resistance patterns in patients failing NNRTI-based treatment: results from a national survey in South Africa

W. MacLeod, I. Sanne, W. Stevens, 2017, The Journal of antimicrobial chemotherapy.

Second-line antiretroviral treatment successfully resuppresses drug-resistant HIV-1 after first-line failure: prospective cohort in Sub-Saharan Africa.

T. F. Rinke de Wit, K. Mandaliya, C. Kityo, 2012, The Journal of infectious diseases.

COHORT PROFILE Cohort Profile: The PharmAccess African

T. F. Rinke de Wit, P. Phanuphak, Patrick C. K. Li, 2022 .

Varied Patterns of HIV-1 Drug Resistance on Failing First-Line Antiretroviral Therapy in South Africa

Ian Sanne, Wendy Stevens, J. Mellors, 2010, Journal of acquired immune deficiency syndromes.

Nucleoside reverse transcriptase inhibitor resistance mutations associated with first-line stavudine-containing antiretroviral therapy: programmatic implications for countries phasing out stavudine.

D. Katzenstein, N. Ford, R. Shafer, 2013, The Journal of infectious diseases.

Unnecessary Antiretroviral Treatment Switches and Accumulation of HIV Resistance Mutations; Two Arguments for Viral Load Monitoring in Africa

T. F. Rinke de Wit, K. Mandaliya, C. Kityo, 2011, Journal of acquired immune deficiency syndromes.

Accumulation of HIV drug resistance mutations in patients failing first-line antiretroviral treatment in South Africa.

W. Stevens, C. Wallis, T. R. D. de Wit, 2012, AIDS research and human retroviruses.

The 2012 southern African ARV drug resistance testing guidelines

Jeffrey D. Klausner, Wendy S. Stevens, Wolfgang Preiser, 2012 .

Ensuring quality: a key consideration in scaling-up HIV-related point-of-care testing programs

Rosanna W. Peeling, Wendy Stevens, John N. Nkengasong, 2016, AIDS.

Cost-effectiveness of laboratory monitoring for management of HIV treatment in sub-Saharan Africa: a model-based analysis

T. R. D. Wit, A. Hill, W. Stevens, 2012, AIDS.

Low risk of contamination with automated and manual excision of dried blood spots for HIV DNA PCR testing in the routine laboratory.

W. Stevens, G. Sherman, Janet C. Patton, 2007, Journal of virological methods.

HIV Viral Load Monitoring Among Patients Receiving Antiretroviral Therapy — Eight Sub-Saharan Africa Countries, 2013–2018

M. Mwasekaga, W. Stevens, J. Mwangi, 2021, MMWR. Morbidity and mortality weekly report.

Previous antiretroviral drug use compromises standard first-line HIV therapy and is mediated through drug-resistance

T. F. Rinke de Wit, K. Mandaliya, T. S. Boender, 2018, Scientific Reports.

Ultra-High-Throughput, Automated Nucleic Acid Detection of Human Immunodeficiency Virus (HIV) for Infant Infection Diagnosis Using the Gen-Probe Aptima HIV-1 Screening Assay

L. Berrie, L. Scott, W. Stevens, 2009, Journal of Clinical Microbiology.

The relative contributions of HIV drug resistance, nonadherence and low-level viremia to viremic episodes on antiretroviral therapy in sub-Saharan Africa.

T. F. Rinke de Wit, K. Mandaliya, T. S. Boender, 2020, AIDS.

Feasibility of HIV point-of-care tests for resource-limited settings: challenges and solutions

Lesley E Scott, Wendy Stevens, Natasha Gous, 2014, BMC Medicine.

Metabolic and anthropometric parameters contribute to ART-mediated CD4+ T cell recovery in HIV-1-infected individuals: an observational study

L. Montaner, E. Papasavvas, L. Azzoni, 2011, Journal of the International AIDS Society.

“I got tested at home, the help came to me”: acceptability and feasibility of home‐based TB testing of household contacts using portable molecular diagnostics in South Africa

C. Denkinger, G. Theron, W. Stevens, 2020, Tropical medicine & international health : TM & IH.

The potential for quality assurance systems to save costs and lives: the case of early infant diagnosis of HIV

P. Vickerman, S. Mboup, J. Ong, 2020, Tropical medicine & international health : TM & IH.

Lopinavir/ritonavir monotherapy after virologic failure of first-line antiretroviral therapy in resource-limited settings

D. Katzenstein, J. Crump, J. Bartlett, 2012, AIDS.

Molecular Detection of Mycobacterium tuberculosis from Stools in Young Children by Use of a Novel Centrifugation-Free Processing Method

D. Alland, P. Banada, C. Denkinger, 2018, Journal of Clinical Microbiology.

Systematic Review of the Performance of HIV Viral Load Technologies on Plasma Samples

R. Peeling, N. Ford, A. Landay, 2014, PloS one.

A comparative analysis of HIV drug resistance interpretation based on short reverse transcriptase sequences versus full sequences

T. F. Rinke de Wit, L. Stuyver, W. Stevens, 2010, AIDS research and therapy.

Slow accumulation of HIV resistance mutations: implications for resource-limited settings?

W. Stevens, 2009, The Journal of infectious diseases.

Implementation of an mHealth App to Promote Engagement During HIV Care and Viral Load Suppression in Johannesburg, South Africa (iThemba Life): Pilot Technical Feasibility and Acceptability Study

Kyle Fyvie, L. Scott, W. Stevens, 2022, JMIR formative research.

Prevalence of Antiretroviral Drug Resistance in Patients Who Are Not Responding to Protease Inhibitor-Based Treatment: Results From the First National Survey in South Africa.

G. V. Van Zyl, W. MacLeod, I. Sanne, 2016, The Journal of infectious diseases.

Randomized Trial of Time-Limited Interruptions of Protease Inhibitor-Based Antiretroviral Therapy (ART) vs. Continuous Therapy for HIV-1 Infection

L. Montaner, R. Gross, L. Morris, 2011, PloS one.

Scale-up of HIV Viral Load Monitoring--Seven Sub-Saharan African Countries.

M. Mwasekaga, K. D. de Cock, J. Nkengasong, 2015, MMWR. Morbidity and mortality weekly report.

The potential use of rifabutin for treatment of patients diagnosed with rifampicin-resistant tuberculosis

R. Warren, L. Scott, W. Stevens, 2018, The Journal of antimicrobial chemotherapy.

Early warning indicators for population-based monitoring of HIV drug resistance in 6 African countries.

T. F. Rinke de Wit, R. Geskus, K. Mandaliya, 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Phased implementation of screening for cryptococcal disease in South Africa.

G. Meintjes, N. Govender, W. Venter, 2012, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

Good clinical laboratory practice (GCLP): the need for a hybrid of good laboratory practice and good clinical practice guidelines/standards for medical testing laboratories conducting clinical trials in developing countries.

W. Stevens, 2003, Quality assurance.

Moderate Levels of Pre-Treatment HIV-1 Antiretroviral Drug Resistance Detected in the First South African National Survey

Dominique Goedhals, Wendy S. Stevens, Ian Sanne, 2016, PloS one.

A Pragmatic Approach to HIV-1 Drug Resistance Determination in Resource-Limited Settings by Use of a Novel Genotyping Assay Targeting the Reverse Transcriptase-Encoding Region Only

T. F. Rinke de Wit, L. Stuyver, C. Kityo, 2013, Journal of Clinical Microbiology.

Protease Inhibitor Resistance Is Uncommon in HIV-1 Subtype C Infected Patients on Failing Second-Line Lopinavir/r-Containing Antiretroviral Therapy in South Africa

J. Mellors, W. Venter, I. Sanne, 2010, AIDS research and treatment.

Estimating the Impact of Plasma HIV-1 RNA Reductions on Heterosexual HIV-1 Transmission Risk

James P. Hughes, Connie Celum, Helen Rees, 2010, PloS one.

Performance of the Abbott SARS-CoV-2 IgG serological assay in South African 2 patients

J. Blackburn, L. Scott, I. Sanne, 2022, PloS one.

Diagnostic Accuracy of Xpert MTB/RIF for Extrapulmonary Tuberculosis Specimens: Establishing a Laboratory Testing Algorithm for South Africa

L. Berrie, M. Nicol, L. Scott, 2014, Journal of Clinical Microbiology.

Guidance for Studies Evaluating the Accuracy of Sputum-Based Tests to Diagnose Tuberculosis.

S. Dorman, D. Alland, K. Steingart, 2019, The Journal of infectious diseases.

A survey of tuberculosis infection control practices at the NIH/NIAID/DAIDS-supported clinical trial sites in low and middle income countries

Christopher Lane, S. Swindells, B. Metchock, 2016, BMC Infectious Diseases.

COVID-19 lockdowns in low- and middle-income countries: Success against COVID-19 at the price of greater costs.

S. Madhi, M. Mendelson, W. Stevens, 2020, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

Risk factors for defaulting from tuberculosis treatment: a prospective cohort study of 301 cases in the Gambia.

W. Stevens, P. Hill, S. Donkor, 2005, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Addressing antiretroviral therapy-related diagnostic coverage gaps across South Africa using a programmatic approach

W. Stevens, D. Glencross, N. Cassim, 2018, African journal of laboratory medicine.

Evaluation of the Abbott m2000 RealTime Human Immunodeficiency Virus Type 1 (HIV-1) Assay for HIV Load Monitoring in South Africa Compared to the Roche Cobas AmpliPrep-Cobas Amplicor, Roche Cobas AmpliPrep-Cobas TaqMan HIV-1, and BioMerieux NucliSENS EasyQ HIV-1 Assays

Wendy Stevens, Lesley E. Scott, Linda Erasmus, 2009, Journal of Clinical Microbiology.

Tree-Based Methods for Discovery of Association between Flow Cytometry Data and Clinical Endpoints

Wendy S. Stevens, Ian Sanne, Andrea S. Foulkes, 2010, Adv. Bioinformatics.

Implementation of Xpert MTB/RIF for routine point-of-care diagnosis of tuberculosis at the primary care level.

Lesley Scott, Ian Sanne, Wendy Stevens, 2012, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

Systematic Review of the Use of Dried Blood Spots for Monitoring HIV Viral Load and for Early Infant Diagnosis

R. Peeling, N. Ford, A. Landay, 2014, PloS one.

Comparison of focus HerpesSelect and Kalon HSV-2 gG2 ELISA serological assays to detect herpes simplex virus type 2 antibodies in a South African population

S. Delany-Moretlwe, H. Weiss, W. Stevens, 2009, Sexually Transmitted Infections.

Molecular characterization of the HIV type 1 subtype C accessory genes vif, vpr, and vpu.

C. Bell, A. Capovilla, W. Stevens, 2007, AIDS research and human retroviruses.

CD4 changes among virologically suppressed patients on antiretroviral therapy: a systematic review and meta-analysis

N. Ford, E. Mills, A. Hill, 2015, Journal of the International AIDS Society.

Impact of the GeneXpert MTB/RIF Technology on Tuberculosis Control.

K. Dheda, N. Gous, L. Scott, 2017, Microbiology spectrum.

A community‐based study to examine the effect of a youth HIV prevention intervention on young people aged 15–24 in South Africa: results of the baseline survey

I. Kleinschmidt, H. Rees, N. Padian, 2005, Tropical medicine & international health : TM & IH.

Association between HIV replication and serum leptin levels: an observational study of a cohort of HIV-1-infected South African women

L. Montaner, E. Papasavvas, R. Gross, 2010, Journal of the International AIDS Society.

Changing Pattern of Lymphoma Subgroups at a Tertiary Academic Complex in a High-Prevalence HIV Setting: A South African Perspective

W. Stevens, T. Wiggill, H. Mantina, 2011, Journal of acquired immune deficiency syndromes.

Performance of the Roche cobas MTB assay for the molecular diagnosis of pulmonary tuberculosis in a high HIV burden setting.

E. Marlowe, L. Scott, W. Stevens, 2020, The Journal of molecular diagnostics : JMD.

A meta-analysis of the performance of the PimaTM CD4 for point of care testing

T. Peter, J. Nkengasong, L. Scott, 2015, BMC Medicine.

Feasibility of Cell-Free DNA Collection and Clonal Immunoglobulin Sequencing in South African Patients With HIV-Associated Lymphoma

Lisa M Haley, W. Stevens, N. Martinson, 2021, JCO global oncology.

Local reference ranges for full blood count and CD4 lymphocyte count testing.

J. Mahlangu, W. Stevens, P. Becker, 2009, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

Natural Killer Cell Activation Distinguishes Mycobacterium tuberculosis–Mediated Immune Reconstitution Syndrome From Chronic HIV and HIV/MTB Coinfection

L. Montaner, L. Azzoni, A. Foulkes, 2011, Journal of acquired immune deficiency syndromes.

HIV-1 Viral Load Assays for Resource-Limited Settings

Cheryl Jennings, Ben Cheng, Wendy Stevens, 2006, PLoS medicine.

Abbott RealTime HIV-1 m2000rt viral load testing: manual extraction versus the automated m2000sp extraction.

J. Crump, W. Venter, L. Scott, 2011, Journal of virological methods.

Drug susceptibility and resistance mutations after first-line failure in resource limited settings.

D. Katzenstein, J. Bartlett, W. Stevens, 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

South African population herpes simplex virus type 2 antibodies in a HSV-2 gG 2 ELISA serological assays to detect Comparison of focus HerpesSelect and Kalon

S. Delany-Moretlwe, H. Weiss, W. Stevens, 2022 .

Building a National HIV Cohort from Routine Laboratory Data: Probabilistic Record-Linkage with Graphs

Jacob Bor, William B. MacLeod, Katia Oleinik, 2018, bioRxiv.

Case report of the rare deletion at codon 69 of reverse transcriptase in a South African HIV-1 subtype C infected patient

W. Stevens, C. Wallis, M. Papathanasopoulos, 2010, Virus Genes.

The Utility of the Lipoprotein-Associated Phospholipase A2 (Lp-PLA2) Assay in Detecting Abnormalities in Lipid Metabolism and Cardiovascular Risk in an HIV-Infected South African Cohort

D. Grobbee, A. Vos, R. Barth, 2019, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Xpert MTB/RIF as a measure of sputum bacillary burden. Variation by HIV status and immunosuppression.

Lesley Scott, Ian Sanne, Wendy Stevens, 2014, American journal of respiratory and critical care medicine.

Protease Inhibitor Resistance in the First 3 Years of Second-Line Antiretroviral Therapy for HIV-1 in Sub-Saharan Africa.

T. F. Rinke de Wit, C. Chimbetete, K. Mandaliya, 2016, The Journal of infectious diseases.

The Center for HIV/AIDS Vaccine Immunology (CHAVI) multi-site quality assurance program for cryopreserved human peripheral blood mononuclear cells.

Guido Ferrari, Marcella Sarzotti-Kelsoe, Wendy S. Stevens, 2014, Journal of immunological methods.

Feasibility of Performing Multiple Point of Care Testing for HIV Anti-Retroviral Treatment Initiation and Monitoring from Multiple or Single Fingersticks

Lesley Scott, Wendy Stevens, Natasha Gous, 2013, PloS one.

Evaluation of the Abbott m2000rt RealTime HIV-1 assay with manual sample preparation compared with the ROCHE COBAS AmpliPrep/AMPLICOR HIV-1 MONITOR v1.5 using specimens from East Africa.

J. Crump, L. Scott, W. Stevens, 2009, Journal of virological methods.

Comparison of Two Human Immunodeficiency Virus (HIV) RNA Surrogate Assays to the Standard HIV RNA Assay

J. Bremer, D. Brambilla, W. Stevens, 2005, Journal of Clinical Microbiology.

South African HIV self-testing policy and guidance considerations

A. Puren, W. Devillé, M. Moorhouse, 2017, Southern African journal of HIV medicine.

Lopinavir/Ritonavir Monotherapy as Second-line Antiretroviral Treatment in Resource-Limited Settings: Week 104 Analysis of AIDS Clinical Trials Group (ACTG) A5230.

D. Katzenstein, J. Crump, J. Bartlett, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

CD4 Enumeration Technologies: A Systematic Review of Test Performance for Determining Eligibility for Antiretroviral Therapy

R. Peeling, N. Ford, A. Landay, 2015, PloS one.

Performance evaluation of the Pima™ point-of-care CD4 analyser using capillary blood sampling in field tests in South Africa

W. Stevens, W. Venter, D. Glencross, 2012, Journal of the International AIDS Society.

Continuous quality monitoring in the field: an evaluation of the performance of the Fio Deki Reader™ for rapid HIV testing in South Africa

Lesley Scott, Wendy Stevens, Lara Noble, 2020, BMC Infectious Diseases.

Utility of clinical parameters to identify HIV infection in infants below ten weeks of age in South Africa: a prospective cohort study

S. Madhi, L. Myer, M. Cotton, 2011, BMC pediatrics.

The Implementation and Appraisal of a Novel Confirmatory HIV-1 Testing Algorithm in the Microbicides Development Programme 301 Trial (MDP301)

S. McCormack, J. Weber, W. Stevens, 2012, PloS one.

Multidisciplinary Point-of-Care Testing in South African Primary Health Care Clinics Accelerates HIV ART Initiation but Does Not Alter Retention in Care

Lesley E Scott, Wendy S Stevens, Ian Sanne, 2017, Journal of acquired immune deficiency syndromes.

Correction: Estimating retention in HIV care accounting for patient transfers: A national laboratory cohort study in South Africa

W. MacLeod, M. Fox, W. Stevens, 2018, PLoS Medicine.

Correction: Performance of the PointCare NOW System for CD4 Counting in HIV Patients Based on Five Independent Evaluations

T. Peter, I. Jani, L. Scott, 2012, PLoS ONE.

Establishing the cost of Xpert MTB/RIF mobile testing in high-burden peri-mining communities in South Africa

W. Stevens, D. Glencross, N. Cassim, 2021, African journal of laboratory medicine.

EMERGENCE OF DRUG RESISTANCE IN HIV-1 SUBTYPE C INFECTED CHILDREN FAILING THE SOUTH AFRICAN NATIONAL ANTIRETROVIRAL ROLL-OUT PROGRAM

W. Stevens, L. Erasmus, C. Wallis, 2009, The Pediatric infectious disease journal.

The Development of a Standardized Quality Assessment Material to Support Xpert® HIV-1 Viral Load Testing for ART Monitoring in South Africa

L. Scott, W. Stevens, P. D. da Silva, 2020, Diagnostics.

Low Rates of Nucleoside Reverse Transcriptase Inhibitor Resistance in a Well-Monitored Cohort in South Africa on Antiretroviral Therapy

R. Wood, C. Orrell, J. McIntyre, 2011, Antiviral therapy.

Diagnostic accuracy and effectiveness of the Xpert MTB/RIF assay for the diagnosis of HIV-associated lymph node tuberculosis

L. Scott, I. Sanne, W. Stevens, 2013, European Journal of Clinical Microbiology & Infectious Diseases.

Erratum: The status of HIV-1 resistance to antiretroviral drugs in sub-Saharan Africa (Antiviral Therapy vol. 13 (625-639))

T. R. D. Wit, W. Stevens, R. Hamers, 2008 .

Prevalence, risk factors and risk perception of tuberculosis infection among medical students and healthcare workers in Johannesburg, South Africa.

W. Venter, L. Scott, W. Stevens, 2013, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

failure: prospective cohort in sub-Saharan Africa

T. R. D. Wit, K. Mandaliya, C. Kityo, 2012 .

A High Burden Human Immunodeficiency Virus and Tuberculosis Resource Limited Setting, Gains from Including Xpert MTB/RIF in the Diagnostic Algorithm of Fluid Specimens Submitted for Exclusion of Lymphoma by Immunophenotypic Analysis

L. Scott, W. Stevens, E. Mayne, 2015, PloS one.

Clinical research and development of tuberculosis diagnostics: moving from silos to synergy.

Wendy S Stevens, Jane Diefenbach, David Alland, 2012, The Journal of infectious diseases.

Clinical Research and Development ofTuberculosis Diagnostics: Moving From Silos toSynergy

M. Perkins, G. Ireton, C. Hamilton, 2012 .

Preparing for the next pandemic: Lessons from rapid scale-up of SARS-CoV-2 testing in a South African high-throughput automated HIV molecular laboratory

W. Stevens, T. Wiggill, K. Steegen, 2021, International Journal of Infectious Diseases.

The utility of repeat Xpert MTB/RIF testing to diagnose tuberculosis in HIV-positive adults with initial negative result

A. Vassall, M. Nicol, S. Charalambous, 2018, Gates Open Research.

Identification of a 251 Gene Expression Signature That Can Accurately Detect M. tuberculosis in Patients with and without HIV Co-Infection

Noor B. Dawany, L. Montaner, L. Azzoni, 2014, PloS one.

Self-Sampling for SARS-CoV-2 Diagnostic Testing by Using Nasal and Saliva Specimens: Protocol for Usability and Clinical Evaluation

L. Scott, W. Stevens, D. Conserve, 2021, JMIR Research Protocols.

Performance of the New Roche Cobas AmpliPrep-Cobas TaqMan Version 2.0 Human Immunodeficiency Virus Type 1 Assay

Lesley Scott, Wendy Stevens, L. Scott, 2009, Journal of Clinical Microbiology.

Accumulation of HIV drug resistance mutations in patients failing first-line antiretroviral treatment in South Africa.

W. Stevens, C. Wallis, T. R. D. de Wit, 2012, AIDS Research and Human Retroviruses.

Natural Killer Cell Activation Distinguishes Mycobacterium tuberculosis–Mediated Immune Reconstitution Syndrome From Chronic HIV and HIV/MTB Coinfection

L. Montaner, L. Azzoni, A. Foulkes, 2011, Journal of acquired immune deficiency syndromes.

Antiretroviral prophylaxis for HIV prevention in heterosexual men and women.

J. Baeten, J. Tappero, D. Bangsberg, 2012, The New England journal of medicine.

Drug-resistant HIV-1 in sub-Saharan Africa: clinical and public health studies

K. Mandaliya, C. Kityo, W. Stevens, 2013 .

Second-line antiretroviral treatment successfully resuppresses drug-resistant HIV-1 after first-line failure: prospective cohort in Sub-Saharan Africa.

T. F. Rinke de Wit, K. Mandaliya, C. Kityo, 2012, The Journal of infectious diseases.

Building capacity for the assessment of HIV drug resistance: experiences from the PharmAccess African Studies to Evaluate Resistance network.

T. F. Rinke de Wit, K. Mandaliya, C. Kityo, 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Effect of pretreatment HIV-1 drug resistance on immunological, virological, and drug-resistance outcomes of first-line antiretroviral treatment in sub-Saharan Africa: a multicentre cohort study.

F. Wit, K. Mandaliya, C. Kityo, 2012, The Lancet. Infectious diseases.

Evaluation of a dried blood spot HIV-1 RNA program for early infant diagnosis and viral load monitoring at rural and remote healthcare facilities

J. Crump, J. Bartlett, S. Lofgren, 2009, AIDS.

Evaluation of an affordable HIV-1 virological failure assay and antiretroviral drug resistance genotyping protocol.

L. Stuyver, T. R. D. Wit, W. Stevens, 2013, Journal of virological methods.

Should South Africa Be Performing Nucleic Acid Testing on HIV Enzyme-Linked Immunosorbent Assay-Negative Samples?

N. Gous, L. Scott, W. Stevens, 2010, Journal of Clinical Microbiology.

Comparison of focus HerpesSelect and Kalon HSV-2 gG2 ELISA serological assays to detect herpes simplex virus type 2 antibodies in a South African population

S. Delany-Moretlwe, H. Weiss, W. Stevens, 2009, Sexually Transmitted Infections.

G. Janossy, I. Sanne, W. Stevens, 2008, Cytometry. Part B, Clinical cytometry.

Early warning indicators for population-based monitoring of HIV drug resistance in 6 African countries.

T. F. Rinke de Wit, R. Geskus, K. Mandaliya, 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Cloud-Based Surveillance, Connectivity, and Distribution of the GeneXpert Analyzers for Diagnosis of Tuberculosis (TB) and Multiple-Drug-Resistant TB in South Africa

Wendy Stevens, Naseem Cassim, Brad Cunningham, 2016 .

HIV prevalence among medical students in Johannesburg, South Africa.

L. Scott, W. Stevens, A. Van Rie, 2009, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

Successes, challenges and lessons from a novel deployment of Xpert(®) MTB/RIF at a major South African public event [Short Communication].

G. Churchyard, L. Scott, W. Stevens, 2014, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Feasibility, Ease-of-Use, and Operational Characteristics of World Health Organization–Recommended Moderate-Complexity Automated Nucleic Acid Amplification Tests for the Detection of Tuberculosis and Resistance to Rifampicin and Isoniazid

W. Stevens, S. Schumacher, A. Trollip, 2022, The Journal of molecular diagnostics : JMD.

Management of rifampicin-resistant TB: programme indicators and care cascade analysis in South Africa.

R. Warren, L. Scott, W. Stevens, 2021, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.